These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22354009)

  • 1. RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.
    Ji S; Xu J; Zhang B; Yao W; Xu W; Wu W; Xu Y; Wang H; Ni Q; Hou H; Yu X
    Cancer Biol Ther; 2012 Feb; 13(4):206-15. PubMed ID: 22354009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
    Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
    Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells.
    Zhang L; Hou S; Mao S; Wei D; Song X; Lu Y
    Int J Pharm; 2004 Dec; 287(1-2):155-62. PubMed ID: 15541922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Fluorescence Imaging and Biological Effects of Peptide Conjugated Quantum Dots on Pancreatic Cancer Cells.
    Shi X; Shi C; Ye W; Wang L; Zhan Y; Song F; Liu F; Shi Y
    J Nanosci Nanotechnol; 2020 Mar; 20(3):1351-1357. PubMed ID: 31492294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor Effect of Nanoparticle
    Ming H; Fang L; Gao J; Li C; Ji Y; Shen Y; Hu Y; Li N; Chang J; Li W; Tan J
    AJR Am J Roentgenol; 2017 May; 208(5):1116-1126. PubMed ID: 28301223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of Epirubicin.
    Zhang L; Li G; Gao M; Liu X; Ji B; Hua R; Zhou Y; Yang Y
    Colloids Surf B Biointerfaces; 2016 Aug; 144():81-89. PubMed ID: 27070055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
    Yadav AS; Radharani NNV; Gorain M; Bulbule A; Shetti D; Roy G; Baby T; Kundu GC
    Nanoscale; 2020 May; 12(19):10664-10684. PubMed ID: 32374338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
    Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and uptake of novel RGD micelles to the αvβ3 integrin receptor for targeted drug delivery.
    Raj A; Saraf P; Javali NM; Li X; Jasti B
    J Drug Target; 2014 Jul; 22(6):518-27. PubMed ID: 24611965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved drug targeting to liver tumor by sorafenib-loaded folate-decorated bovine serum albumin nanoparticles.
    Wang H; Sun S; Zhang Y; Wang J; Zhang S; Yao X; Chen L; Gao Z; Xie B
    Drug Deliv; 2019 Dec; 26(1):89-97. PubMed ID: 30744448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-loaded albumin nanoparticle and study their internalization effect by using β-cyclodextrin.
    Tiwari R; Viswanathan K; Gour V; Vyas SP; Soni V
    J Recept Signal Transduct Res; 2021 Aug; 41(4):393-400. PubMed ID: 32900251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Conjugated Quantum Dots Act as the Target Marker for Human Pancreatic Carcinoma Cells.
    Li SL; Yang J; Lei XF; Zhang JN; Yang HL; Li K; Xu CQ
    Cell Physiol Biochem; 2016; 38(3):1121-8. PubMed ID: 26963791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
    Babu A; Amreddy N; Muralidharan R; Pathuri G; Gali H; Chen A; Zhao YD; Munshi A; Ramesh R
    Sci Rep; 2017 Nov; 7(1):14674. PubMed ID: 29116098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic-assisted preparation of RGD-decorated nanoparticles: exploring integrin-facilitated uptake in cancer cell lines.
    Rios De La Rosa JM; Spadea A; Donno R; Lallana E; Lu Y; Puri S; Caswell P; Lawrence MJ; Ashford M; Tirelli N
    Sci Rep; 2020 Sep; 10(1):14505. PubMed ID: 32879363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimeric System of RGD-Grafted PMMA-Nanoparticles as a Targeted Drug- Delivery System for Paclitaxel.
    Gibbens-Bandala BV; Ocampo-García BE; Ferro-Flores G; Morales-Avila E; Ancira-Cortez A; Jaimes-Aguirre L
    Curr Pharm Des; 2017; 23(23):3415-3422. PubMed ID: 28403791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
    Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
    Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
    Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
    J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
    Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
    Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.